SWISS HELVETIA FUND
Swiss Helvetia Fund is a non-diversified, closed-end investment company whose objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The Fund also may acquire and hold equity and equity-linked securities of non-Swiss companies in limited instances.
SWISS HELVETIA FUND
Industry:
Financial Services
Founded:
1986-01-01
Status:
Active
Technology used in webpage:
SPF Nginx DOSarrest Uniregistry
Current Advisors List
Current Employees Featured
Stock Details
Company's stock symbol is NYSE:SWZ
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-08-18 | Kuros Biosciences | Swiss Helvetia Fund investment in Post-IPO Equity - Kuros Biosciences | 15.35 M USD |
| 2012-01-09 | Selfrag | Swiss Helvetia Fund investment in Series C - Selfrag | 9.1 M CHF |
| 2010-10-12 | Synosia Therapeutics | Swiss Helvetia Fund investment in Series C - Synosia Therapeutics | 30 M USD |
| 2009-01-01 | Synosia Therapeutics | Swiss Helvetia Fund investment in Series B - Synosia Therapeutics | 29 M USD |